Protein discovery reveals potential treatment target for common fatty liver disease
The mechanisms that cause the world's most common chronic liver disease—metabolic dysfunction-associated steatotic liver disease (MASLD)—to develop and progress are still not fully understood.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Higher ADK levels track stronger triciribine effects in leukemia cells, pointing to a potential biomarker
United Kingdom
-
DNA once dismissed as 'noise' reveals new bacterial species in prostate cancer patients
United Kingdom
-
AI facial health recognition tools help physicians assess age and survival risk to guide personalized treatment
United Kingdom
-
Embryos harbor immune cells that already perform adult-like defense functions, study suggests
United Kingdom
-
Home sensor system could spot loneliness in older adults
United Kingdom
-
Difficult times in agriculture are making it tough for the next generation of farmers
United States
-
Percival AI can uncover unseen health issues in CT scans
United Kingdom
-
Advanced paternal age has sex-specific effects on fetal brain gene expression, mouse study suggests
United Kingdom